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Abstract
Background: Offspring of asthmatic mothers have increased risk of developing asthma, based on
human epidemiologic data and experimental animal models. The objective of this study was to
determine whether maternal allergy at non-pulmonary sites can increase asthma risk in offspring.
Methods: BALB/c female mice received 2 topical applications of vehicle, dinitrochlorobenzene, or
toluene diisocyanate before mating with untreated males. Dinitrochlorobenzene is a skin-sensitizer
only and known to induce a Th1 response, while toluene diisocyanate is both a skin and respiratory
sensitizer that causes a Th2 response. Both cause allergic contact dermatitis. Offspring underwent
an intentionally suboptimal protocol of allergen sensitization and aerosol challenge, followed by
evaluation of airway hyperresponsiveness, allergic airway inflammation, and cytokine production.
Mothers were tested for allergic airway disease, evidence of dermatitis, cellularity of the draining
lymph nodes, and systemic cytokine levels. The role of interleukin-4 was also explored using
interleukin-4 deficient mice.
Results:  Offspring of toluene diisocyanate but not dinitrochlorobenzene-treated mothers
developed an asthmatic phenotype following allergen sensitization and challenge, seen as increased
Penh values, airway inflammation, bronchoalveolar lavage total cell counts and eosinophilia, and Th2
cytokine imbalance in the lung. Toluene diisocyanate treated interleukin-4 deficient mothers were
able to transfer asthma risk to offspring. Mothers in both experimental groups developed allergic
contact dermatitis, but not allergic airway disease.
Conclusion:  Maternal non-respiratory allergy (Th2-skewed dermatitis caused by toluene
diisocyanate) can result in the maternal transmission of asthma risk in mice.
Background
Asthma is a significant cause of morbidity and mortality
[1] whose prevalence has almost doubled in the past 20
years [2]. The pathogenesis of asthma is multifactorial and
not entirely understood. However, maternal asthma is a
known risk factor for asthma in children [3-5]. There is
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also evidence in mice and humans that allergic sensitiza-
tion may occur in the prenatal period [6-8]. This maternal
association taken together with prenatal sensitization
data, implies that some component(s) of the in utero envi-
ronment may be causing increased asthma risk in off-
spring.
To investigate the mechanisms that mediate the maternal
transfer of asthma risk, we developed a murine model in
which offspring of asthmatic BALB/c female mice show
higher asthma susceptibility than normal babies. Specifi-
cally, babies of ovalbumin (OVA)-sensitized and chal-
lenged mothers develop an asthma-like syndrome in
response to an intentionally suboptimal protocol of aller-
gen sensitization that has little effect on normal babies [9-
11]. We have also recently reported that the adoptive
transfer of allergen-specific T cells [12] is sufficient to rec-
reate the maternal transfer of asthma risk, even though
recipient mothers do not show detectable signs of allergic
airway disease.
This finding suggested that the maternal effect occurs
through systemic production of allergic mediators rather
than asthma per se. We therefore postulated that various
allergic stimuli could similarly increase the risk of asthma
in offspring. To test this hypothesis we induced allergic
contact dermatitis (ACD) in BALB/c female mice through
topical applications of toluene diisocyanate (TDI) or din-
itrochlorobenzene (DNCB), mated them, and assessed
their offspring for asthma risk. Although both chemicals
are potent skin sensitizers, TDI provokes Th2-dominated
responses [13-16] and is also a known respiratory sensi-
tizer implicated in occupational asthma after inhalation
exposures [17]. Conversely, DNCB is considered a strict
contact allergen that stimulates a Th1-type pattern of
cytokine secretion [13,18] and has no reported effects on
the airways [19]. Our data showed that maternal ACD
mediated by TDI, but not by DNCB, results in increased
asthma susceptibility in offspring. Since we previously
found that IL-4 plays a prominent role in the maternal
effect in OVA-allergic mothers [9], we also investigated its
role by using IL-4 deficient mice in the ACD model.
Methods
Animals
Male and female BALB/c mice, 8–10 week-old were
obtained commercially from Charles River Laboratories
(Wilmington, MA). IL-4 knockout mice (BALB/c back-
ground) were obtained from Jackson Laboratories (BALB/
c-Il4tm2Nnt/J, stock number 002496)[20]. Mice were
housed and fed standard lab chow ad libitum in a patho-
gen-free barrier facility that was maintained at 22–24°C
with a 12-h dark/light cycle. Animal experiments were
conducted under a protocol approved by our institutional
review board.
TDI/DNCB-induced ACD
Our original model using ovalbumin (OVA)-sensitized
and OVA aerosol-challenged mother mice was detailed
elsewhere [9]. Normal BALB/c female mice received 2 top-
ical applications on their backs (day 0 and 7) of either
vehicle only (a mixture of acetone and mineral oil, 4:1,
v:v), or 50 μl of 2% dinitrochlorobenzene (DNCB, Sigma-
Aldrich, Saint Louis, MO), or 50 μl of 2% toluene diisocy-
anate (TDI, Sigma-Aldrich). The females were allowed to
mate with normal BALB/c males 24 hours after the second
chemical application (day 8). In some experiments, con-
trols and treated mice received topical application of 1%
hydrocortisone acetate (GC) on day 7 (4 hours after sec-
ond chemical application) and day 8 (before mating) of
the protocol. Additional GC applications were then per-
formed every 4 days during the whole pregnancy.
Allergen sensitization and challenge
Offspring of treated/untreated mother mice were submit-
ted to an intentionally suboptimal asthma induction pro-
tocol (see Fig. 1) that features only one single i.p. injection
of 5 μg OVA in 1 mg Al(OH)3 on day 4 of life, followed
by 3% OVA aerosols on days 12–14. Final physiologic and
pathologic analyses were performed on days 15 and 16,
respectively.
Histology
Mother and baby mouse lungs were inflated with 10%
buffered formalin, removed, and immersed in the same
solution. In the case of skin samples, approximately half a
square inch of the chemically-treated area was collected
on day 15 of the protocol (1 week after second applica-
tion) and immediately similarly fixed in 10% buffered
formalin. All the tissue samples were embedded in paraf-
fin and sections for microscopy were stained with hema-
toxylin and eosin (H&E).
Cellularity in superficial cervical lymph nodes
The draining lymph nodes were collected from treated/
untreated female mice 24 hours after topical application
Schematic of main protocol Figure 1
Schematic of main protocol. Vehicle, 2%TDI, or 2%DNCB 
was applied to wild-type female BALB/c mice on day 0 and 7, 
followed by mating on day 8. Offspring received one i.p. 
injection of OVA/Alum at day 4 of life, 10 minute aerosol 
challenges with 3% OVA on days 12–14, followed by analyses 
on days 15 and 16.Respiratory Research 2007, 8:56 http://respiratory-research.com/content/8/1/56
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of DNCB and TDI. The 4 lymph nodes from each animal
were rinsed in PBS and incubated for 1 hour (37°C) in 1
ml RPMI containing 10% fetal calf serum (FCS) and 1 mg
collagenase D (Roche Diagnostics Corporation, Indianap-
olis, IN). The cells were then expelled through a 70-μm
nylon mesh filter, washed in RPMI (10% FCS), and finally
resuspended in PBS. Total cell counts per mouse (4 lymph
nodes each) were determined by means of a hemocytom-
eter.
Pulmonary function testing and pathologic analysis
Airway bronchoconstriction in response to increasing
concentration (0–100 mg/ml) of aerosolized metha-
choline (MCh) was evaluated in mothers and offspring 24
hours after last allergen exposure (chemicals or OVA)
using unrestrained plethysmography (Buxco, Sharon,
CT). The use of unrestrained plethysmography and
enhanced pause (Penh) as surrogate of the mouse lung
function has important limitations [21]. However, in
BALB/c mice, from which the present results were exclu-
sively obtained, enhanced pause (Penh) correlates well
with invasive measures of lung resistance [22]. It is also
worth noting that our models use cohorts of 2 week-old
baby mice that are too small to be tested through invasive
techniques and make unrestrained plethysmography a
more appropriate technique [23]. Bronchoalveolar lavage
(BAL) was performed on euthanized animals 48 hours
after last allergen challenge (day 9 of the protocol for
mothers, day 16 of life for offspring). Total cell yield was
quantified by hemocytometer. BAL differential cell count
was performed on cytocentrifuge slides stained with Diff-
Quick (VWR, Boston, MA).
Multiplex cytokine immunoassay
Serum samples were collected from each group of female
mice at week 1, 2, and 3 of pregnancy and the offspring at
time of euthanasia. Circulating cytokines were quanti-
tated using multiplex biomarker immunoassays from
Linco Research (St Charles, MI) and xMAP technology
(Luminex, Austin, TX) according to the manufacturer's
instructions. Standards and internal controls were added
for each cytokine and diluted in serum-like medium. Raw
data were analyzed using Masterplex QT 2.0 software
(Luminex). Graphs are representative of data averaged
from 3 to 5 animals per group, each sample assayed in
duplicates. Final concentrations were expressed in pg/ml
± SEM. Concentrations plotted as 'zero' on the graphs
were below detection limits.
Statistical analysis
All data are presented as means ± SEM. Differences
between groups were compared using one-way or two way
ANOVA with protected least significant differences
(PLSD) Fisher's test and Bonferroni post-tests. Prism
GraphPad and StatView software program (Abacus Con-
cepts, Berkeley, CA) were used for all statistical analysis. A
p value < 0.05 was considered significant.
Results
Evaluation of maternal skin and respiratory responses
After both DNCB and TDI application, macroscopic
changes including hair loss and local erythema were seen
(Fig. 2B and 2C, respectively). Histopathology of the skin
at the area of chemical irritant application showed
increased dermal thickness (Fig. 2E – DNCB and Fig. 2F –
TDI) and inflammation. While the local skin lesions were
similar, only the TDI treated group showed showed
increased cellularity in draining lymph nodes, as com-
pared to vehicle- and DNCB-treated mothers (Fig. 2G).
Although TDI is a known respiratory sensitizer, it is not
known to cause airway disease after exposures limited to
topical skin contact. We performed a series of analyses to
more directly determine the effects, if any, on the airways
of mothers treated topically in our protocols. Histopatho-
logic evaluation of maternal lungs showed normal struc-
ture (Fig. 3A – Vehicle, 3B – DNCB, and 3C – TDI). BAL
total cell and differential counts were similar in mothers
across all treatment groups (Fig. 3D and 3E). Airway
responsiveness was similarly minimal in all groups (Fig.
3F). The serum cytokine levels in all groups showed statis-
tically equal and low amounts of GM-CSF, IL13, IFN-g,
and IL-5 (p values > 0.05). IL-4 levels were below the lim-
its of detection in all groups (data not shown). These data
indicate that the mothers in all treatment groups did not
have signs of allergic respiratory disease.
Increased Asthma Susceptibility in Offspring of TDI 
treated mothers
Female mice were treated topically twice with vehicle,
DNCB, and TDI, mated, and their offspring were sub-
jected to the protocol summarized in Fig. 1. Histologic
evaluation showed markedly increased inflammatory
infiltration in the lung samples of the offspring of TDI-
treated mothers (TDI offspring, Fig 4C) compared to off-
spring of DNCB- and vehicle-treated mothers (DNCB off-
spring and vehicle offspring; Fig 4B and 4A, respectively).
This infiltrate was primarily found around airways and
vessels, and composed of mononuclear cells and eosi-
nophils. Quantitative analysis of bronchoalveolar lavage
confirmed the qualitative histologic findings. We found
significantly increased total cell counts in the TDI off-
spring, as compared to the DNCB and vehicle offspring
(Fig. 4D, p < 0.05). Further, the TDI offspring showed sig-
nificantly increased eosinophilia (Fig. 4E, p < 0.05). Air-
way responsiveness, as measured using unrestrained
plethysmography, was also increased in the TDI offspring
at all methacholine concentrations as compared to DNCB
offspring and vehicle offspring (Fig. 4F, p < 0.05). The
cytokine profile in the BAL of the TDI offspring showed
Th2 skewing, with significantly increased IL-4, IL-5, andRespiratory Research 2007, 8:56 http://respiratory-research.com/content/8/1/56
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IL-13 (Fig. 5, p < 0.05). IFN-g and IL-10 showed a trend
toward decrease in the TDI offspring as compared to vehi-
cle and DNCB offspring, although this did not achieve sta-
tistical significance.
Topical treatment with glucocorticoids after development 
of ACD from TDI exposure
We sought to test the postulate that therapeutic modula-
tion of the TDI-mediated ACD would reduce the increased
asthma susceptibility observed in the TDI offspring. To
this end, after induction of ACD with TDI or DNCB, glu-
cocorticoids (TDI-GC or DNCB-GC) were applied to the
skin lesions on 2 separate occasions prior to mating. We
found no effect of the GC therapy. For the TDI and TDI-
GC groups, the BAL total cell counts (140,000 ± 20,745
and 175,833 ± 16,235, respectively) and percentage eosi-
nophilia (48% ± 7.34 and 56% ± 4.76, respectively) were
statistically similar (p > 0.05). The Penh values were also
similar between these two groups (p > 0.05). Both the TDI
and TDI-GC group showed statistically increased total cell
count, percentage eosinophilia, and Penh compared to
negative controls. For the DNCB and DNCB-GC groups,
BAL total cell counts, percentage eosinophilia, Penh were
statistically similar (p > 0.05) and no different then nega-
tive controls (p > 0.05). Also after application of the GC,
no visible change in the ACD lesions was noted.
Effect of vehicle, DNCB, and TDI on adult female mice Figure 2
Effect of vehicle, DNCB, and TDI on adult female mice. 2A-C shows gross appearance of skin after 2nd application of irritant 
(vehicle, DNCB, TDI; respectively). 2D-F shows inflammation of dermal layers in DNCB (2E) and TDI (2F) treated mice com-
pared to vehicle (2D) treated mice. 2G shows increased lymph node cellularity in TDI group compared to others (*p < 0.005).Respiratory Research 2007, 8:56 http://respiratory-research.com/content/8/1/56
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IL-4KO mothers transfer asthma susceptibility
In a prior study, injections of IL-4 monoclonal antibody
(mab) in OVA-sensitized and challenged mothers attenu-
ated the maternal effect, implying that this cytokine
played a significant mechanistic role in the maternal
transfer of asthma risk. To examine the role of IL-4 in the
maternal transfer seen using the ACD model, we per-
formed experiments using IL-4 KO females. After induc-
tion of ACD, IL-4 KO females were mated with normal
males, and their heterozygote offspring tested in the pro-
tocol summarized in Fig. 1.
The offspring of wild type mothers treated with TDI
(WT+TDI offspring) and the offspring of IL-4KO mothers
treated with TDI (IL-4KO+TDI offspring) both had signif-
icantly increased BAL cell counts as compared to offspring
of untreated mothers (WT NO-TDI offspring) (Figure 6A).
Cell counts were not significantly different between
WT+TDI offspring and IL-4KO+TDI offspring. Differential
counts showed statistically increased eosinophilia in both
the WT+TDI offspring and IL-4KO+TDI offspring as com-
pared to negative control offspring (Fig. 6B, p < 0.05).
Penh values for the TDI treated groups (WT+TDI offspring
and IL-4KO+TDI offspring) were also both significantly
higher as compared to negative controls (Fig. 6C, p <
0.05). The increased Penh values for the IL-4KO+TDI off-
spring and WT+TDI offspring were similar, except for
slightly greater Penh in the IL-4KO group at the highest
methacholine concentration.
Discussion
The goal of these experiments was to determine if non-res-
piratory allergy can result in the maternal transmission of
asthma risk. Expanding on a previously described mouse
model, we recently observed that maternal asthma per se
was not needed to transfer asthma risk. The mothers
needed only to be injected with DO11.10 T-cells (which
bear an OVA-specific T cell receptor) and receive OVA
challenge prior to mating to increase the asthma suscepti-
bility in offspring (16). Based on these data, we postulated
that any maternal Th2-skewed allergic state might simi-
larly increase asthma susceptibility in offspring. In the
current study we tested this hypothesis by inducing ACD
in mothers using Th1 or Th2 inducing skin irritants
(DNCB or TDI, respectively) and assessing the offspring
for susceptibility to develop an asthmatic phenotype. The
offspring of mothers with DNCB-ACD and those treated
with vehicle alone did not have increased susceptibility,
while the offspring of the TDI-ACD mothers did show
allergic airway inflammation and increased Penh
responses to methacholine. Moreover, the cytokine pro-
file of the offspring for the TDI group was Th2 skewed as
compared to DNCB and control groups. Hence by multi-
ple criteria, these pups exhibited an asthma-like pheno-
type after the intentionally suboptimal protocol used in
our models (Fig 1). Although both the DNCB and TDI
treated groups had significant and similar degrees of ACD,
it is noteworthy that the mothers' airways showed find-
ings essentially identical to controls, with no evidence of
pulmonary inflammation. Thus, the data indicate that
transfer of asthma susceptibility can follow a maternal
allergic (Th2) response in another tissue site without a
requirement for pulmonary allergy.
As maternal ACD caused increased susceptibility to
asthma in offspring, we postulated that modulation of the
ACD might affect transmission of asthma risk. However,
treatment of the lesions with topical glucocorticoids did
not affect the offspring's response to the suboptimal pro-
tocol. Since no gross difference was seen in the ACD
lesions between GC-treated and untreated groups, the
dose used may have been insufficient. Another possibility
is the timing of treatment (after the second topical appli-
cation) missed an earlier therapeutic window.
Because in a prior study, the maternal effect could be
attenuated with a single injection of IL-4 mab, we postu-
lated that IL-4 could also play a pivotal role in the mater-
nal transmission of asthma in the TDI ACD group. We
predicted that mothers who lacked IL-4 production would
have decreased ability to transmit asthma risk to off-
Effect of vehicle, DNCB, and TDI on airways of adult female  mice Figure 3
Effect of vehicle, DNCB, and TDI on airways of adult female 
mice. 3A-C shows normal histology of airways of mothers 
treated with DNCB (B) and TDI (C), similar to vehicle (A). 
3D and E show that all groups had similar BAL total cell 
counts and percentage eosinophils. 3F shows similar minimal 
responsiveness to methacholine as measured by Penh in all 
groups.Respiratory Research 2007, 8:56 http://respiratory-research.com/content/8/1/56
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spring. Instead, the offspring of IL-4KO mothers treated
with TDI had increased asthma susceptibility similar to
that seen in offspring of wild-type mothers. This argues
against IL-4 alone as a required mediator of the TDI-
induced maternal effect. This may indicate that in the
original study, the IL-4 mab was crossing the placenta and
acting directly on the fetus, rather then acting primarily on
the mother, though that seems unlikely based on the
design of that study (injection pre-mating). More likely,
this finding indicates differences in the mechanisms of
maternal transmission of asthma risk in the two models.
A study by Matheson et al [14] showed that their model of
TDI induced asthma required depletion of both IL-4 and
IL-13 in order to ablate the asthmatic phenotype. It may
be that deficiency in both these Th2 cytokines is required
for abrogation of the maternal effect in a TDI-ACD model,
a postulate that may be amenable to direct testing in
future studies.
There are some limitations of this study that merit discus-
sion. In experiments using IL-4KO, there were statistically
significant differences in Penh, cell counts and differen-
tials. However, the absolute values were decreased as com-
pared to other experiments using wild-type mice. Because
duplicate experiments showed similar results, we consider
the results valid for interpretation as not supporting a crit-
ical role for IL-4 in the TDI-ACD group. A second limita-
tion is the use of unrestrained plethymography, whose use
has become controversial. However, in BALB/c mice, from
which the present results were exclusively obtained, Penh
has proven to highly correlate with lung resistance [22].
Further, the Penh measurements were correlated with cell
counts, differentials, and histopathology. Also, more inva-
sive means of measuring airway dynamics are not possible
in the 2 week old animals studied in our protocol. A third
issue in this study relates to the increase in lymph node
cellularity seen in the TDI versus DNCB treated mothers.
Maternal ACD and offspring susceptibility to OVA-induced asthma Figure 4
Maternal ACD and offspring susceptibility to OVA-induced asthma. Following the suboptimal protocol, an increase in mononu-
clear and eosinophilic cells is seen in airways of offspring from mothers treated with TDI (C), versus DNCB (B) and vehicle-
treated mothers (A). Total cell counts and eosinophil percentages are higher in TDI offspring (4D-E, *p < 0.05). Penh values 
were elevated in TDI offspring (4F, *p < 0.05).Respiratory Research 2007, 8:56 http://respiratory-research.com/content/8/1/56
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One previous study by Lee et al [24] also examined the cel-
lularity of draining lymph nodes following TDI and
DNCB exposure at various concentrations. They found
that, at higher concentration of DNCB (0.5%–1%) and at
all concentrations of TDI, treated mice had increased cel-
lularity as compared to vehicle. However, the TDI treat-
ment group did appear to have increased cellularity as
compared to DNCB. This apparent disagreement with our
data may be due to a difference in technique. Their mice
received the irritants on 3 consecutive days, rather then
twice spaced apart by 7 days. However the importance of
this apparent disagreement is difficult to assess as it is not
clear that the differences in the cited study were statisti-
cally significant.
The data obtained in this study support the conclusion
that a Th2 dominated-allergic response, regardless of tis-
sue site, is sufficient for the maternal transmission of
asthma risk. Although this study does not resolve the
mechanisms involved, it does allow exclusion of some
possibilities and raises some interesting issues. Based on
this and previous studies, specific maternal antibodies or
immunoglobulins are not required to transfer risk, as
increased susceptibility to OVA-allergy was seen in off-
spring of mothers who were OVA-naive. Our study also
rules out a requisite role for IL-4 in the TDI-ACD maternal
effect, as IL-4KO mothers were able transmit asthma sus-
ceptibility to their offspring. We did not find evidence that
maternal serum cytokine levels impact maternal transfer
of asthma risk, as in all groups, the serum levels of multi-
ple Th1 and Th2 cytokines were not significantly different,
although an exhaustive analysis of multiple cytokines and
timepoints was not done, precluding definitive interpreta-
tion of these negative results.
The only difference observed between the vehicle, DNCB,
and TDI mothers was the cellularity of their lymph nodes.
We speculate that important clues for the mechanisms for
maternal transmission of asthma may be found by analy-
sis of the cell types expanded in the nodes. A specific issue
to be addressed is raised by the recent finding that DNCB
may induce a mixed Th1/Th2 response under certain cir-
cumstances. In a recent study by Vanoirbeek et al [25], it
was shown that mice sensitized and then exposed to
DNCB had increases in Con A-stimulated IL-4 release by
cultured lymph node lymphocytes. Evaluation of the
lymph node populations and function (e.g., cytokine
secretion) has proven useful in numerous previous studies
focused on ACD pathogenesis. For example, ACD is
known to cause migration of Langerhans cells (LC) and
dermal dendritic cells (DC) to draining lymph nodes,
after they have encountered and internalized antigen
found in the skin. Once at the draining nodes, they cause
expansion of a receptive sub-population of T-lymphocytes
[26]. It is likely that the ACD caused by the Th2 skewing
contact irritant causes increased migration of LC and DC
to the draining nodes, which cause a clonal expansion of
a subset of T-cells. This subset may then be responsible for
the maternal effect. Prior studies have shown that CD4+T-
cells are essential for the development of isocyanate
induced asthma [14,27], and the latter study showed that
CD8+T-cells are important for the induction of dermatitis.
One or both of these subsets may be the T-cell subset seen
in the draining lymph nodes of the TDI treated mother
mice. The TDI-ACD model will allow further analysis of
whether and how these subsets play a pivotal role in the
maternal transmission of asthma risk.
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IL-4 and ACD-mediated maternal transmission of asthma risk Figure 6
IL-4 and ACD-mediated maternal transmission of asthma 
risk. BAL total cell counts and percentage eosinophils in 
IL4KO+TDI and WT+TDI offspring were elevated compared 
to WT NO-TDI offspring (Fig A and B, *p < 0.05). Penh val-
ues for IL4KO+TDI and WT+TDI offspring were significantly 
greater than WT NO-TDI offspring (Fig C, *p < 0.05). Penh 
for IL4KO+TDI and WT+TDI offspring were statistically 
similar, except at 100 mg/ml methacholine (**p < 0.05).